Lifecore Biomedical

About Lifecore Biomedical

Lifecore Biomedical is a sterile injectable CDMO and sodium hyaluronate producer, specializing in parenteral expertise for specialty formulation, aseptic filling, and final packaging of complex injectable medical devices and pharmaceutical drug products. They aim to support partners from concept to commercial supply with a focus on quality, expertise, and experience.

Products & Services

Process Development:Supports scaling drug products from concept to commercial supply by addressing end goals from the start.

Clinical & Commercial Manufacturing:Handles unique clinical or commercial requirements from production to shipping.

Analytical & Stability Services:Offers on-site labs for greater control of samples and timelines, minimizing risk for customers.

Premium Sodium Hyaluronate:Provides non-animal-sourced, U.S.-made products in various molecular weights, including standard products, modifications, and hydrogels for research, clinical, and commercial applications.

Specialties

Sterile Injectable CDMO Sodium Hyaluronate Production Parenteral Formulation Aseptic Filling Final Packaging of Injectable Medical Devices and Drug Products Handling Highly Viscous Products (>100,000 cP)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Asset Sale Proceeds T: - FT: Asset Sale Proceeds	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2025-06-12 FD: 2025-06-12	-
2	RT: Debt T: - FT: Debt	A: 24300000 MR: - FA: $24.3 million FAN: 24300000	D: 2024-11-26 FD: 2024-11-26	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 24300000 MR: - FA: 24.3 million FAN: 24300000	D: 2024-10-04 FD: 2024-10-04	1 investors
4	RT: Debt T: - FT: Debt	A: 8000000 MR: - FA: 8 million FAN: 8000000	D: 2024-05-16 FD: 2024-05-16	2 investors
5	RT: Debt T: - FT: Debt	A: 150000000 MR: - FA: $150.0 million FAN: 150000000	D: 2023-05-22 FD: 2023-05-22	1 investors
6	RT: Series A Private Placement T: - FT: Series A Private Placement	A: 38750000 MR: - FA: 38.75 million FAN: 38750000	D: 2023-01-09 FD: 2023-01-09	5 investors

Asset Sale Proceeds Latest

2025-06-12

$10.0M

Debt 2024-11-26

$24.3M

Private Placement 2024-10-04

$24.3M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dr. Otto Sartorius

Founder

P

Paul Josephs

President & CEO

R

Ryan D. Lake

Chief Financial Officer

T

Tom Salus

Chief Legal and Administration Officer

J

Jackie Klecker

Executive Vice President, Quality and Development Services

T

Thomas Guldager

Sr. Vice President, Operations

View 10 more team members with Pro

Unlock Full Team Directory

Recent News